Charles River Labs appoints Flavia Pease as CFO; David Smith retires to Senior Advisor

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Flavia Pease named Corporate EVP and CFO effective after Q1 2022 10-Q filing (~early May 2022).
Pease joins from J&J, where she was VP and Group CFO of global Medical Devices ($27B revenue).
Outgoing CFO David Smith will become Senior Financial Advisor until February 2023.
Pease receives $600K base salary, 70% target bonus, $2M equity award, plus $1.7M new-hire equity.
One-time signing bonus of $800,000, with $200K within 30 days and $600K after 12 months.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Flavia H. Pease

Corporate Executive Vice President and Chief Financial Officer

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filed: March 28, 2022, 7:59 PM ET

On March 28, 2022, the Company announced the appointment of Flavia H. Pease as its Corporate Vice President and Chief Financial Officer.

Role change

David R. Smith

Corporate Executive Vice President and Chief Financial Officer

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Successor: Flavia H. Pease
Filed: March 28, 2022, 7:59 PM ET

Mr. Smith will step down from his position as Corporate Executive Vice President and Chief Financial Officer in connection with Flavia H. Pease’s appointment as the Company’s new Corporate Executive Vice President and Chief Financial Officer (as discussed below).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Flavia H. Pease was appointed as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action: appointed
Role: Corporate Executive Vice President and Chief Financial Officer

Exact text from the filing

On March 28, 2022, the Company announced the appointment of Flavia H. Pease as its Corporate Vice President and Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David R. Smith retired as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..

Action: retired
Role: Corporate Executive Vice President and Chief Financial Officer

Exact text from the filing

Mr. Smith will step down from his position as Corporate Executive Vice President and Chief Financial Officer in connection with Flavia H. Pease’s appointment as the Company’s new Corporate Executive Vice President and Chief Financial Officer (as discussed below).

View on SEC.gov

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filing history →

Source: SEC EDGAR

accession 0001100682-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.